Table 4.
Lipoprotein biomarker values before (baseline) and after a 8-week ingestion of control or saury oil supplement
| Baseline (n=30) | Control oil (n=30) | Saury oil (n=30) | ||||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |
| Lipid/Lipoprotein profile | ||||||
| TG (mg/dL) | 64.3 | 26.2 | 52 | 21.1 * | 56.1 | 26.5 * |
| TC (mg/dL) | 174.8 | 48.6 | 184.3 | 45.6 * | 181.7 | 50.9 * |
| LDL-C (mg/dL) | 95.5 | 47.5 | 102.7 | 45.2 * | 98.6 | 50.6 |
| sdLDL (mg/dL) | 26.5 | 15.4 | 29.7 | 16.4 * | 29 | 17.9 |
| oxLDL (U/L) | 73.3 | 24.8 | 75.3 | 24.8 | 72.9 | 26.1 |
| LDL-TG (mg/dL) | 14.6 | 6.4 | 14.4 | 6.3 | 14.7 | 5.7 |
| HDL-C (mg/dL) | 64.4 | 18 | 67.9 | 16.9 * | 68.7 | 19.7 * |
| ApoE-HDL (mg/dL) | 5.9 | 1.9 | 6.3 | 1.7 * | 6.5 | 2.1 * |
| Apolipoproteins | ||||||
| ApoA-I (mg/dL) | 155.6 | 30.5 | 158.3 | 26.3 | 156.1 | 30.4 |
| ApoB (mg/dL) | 85.97 | 33.6 | 91.4 | 31.1 * | 89 | 33.8 |
TG: triglycerides; TC: total cholesterol; LDL-C: LDL cholesterol; sdLDL: small dense LDL; oxLDL: oxidized LDL; LDL-TG: TG concentration in LDL; HDL-C: HDL cholesterol; ApoE-HDL: ApoE-containing HDL. Data represented as mean ± SD (n = 30).
*
P <0.05
**
P <0.01 compared with baseline. No statistical difference were detected in all the reported parameters between the control and saury oil supplements based on a linear mixed effect model.